Evidence map›Paper›PMID 41591847›Full record

ArticleNucleic acids research2026

Expanding the landscape of BREX diversity: uncovering multi-layered functional frameworks and identification of novel BREX-related defense systems.

Siuli Rakesh, Arunkumar Krishnan

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Siuli RakeshDepartment of Biological Sciences, Indian Institute of Science Education and Research Berhampur (IISER Berhampur), Berhampur 760010, India.ORCID 0009-0007-5425-9017
Arunkumar KrishnanDepartment of Biological Sciences, Indian Institute of Science Education and Research Berhampur (IISER Berhampur), Berhampur 760010, India.ORCID 0000-0002-9677-9092

Funding

CSIRDepartment of Biotechnology BT/RLF/Re-entry/64/202IISER
6 · The paper itself

Abstract

Despite extensive scrutiny of BREX systems, several overarching questions persist regarding the functional modalities of individual components and the collective mechanistic framework underlying their defense responses. Using comparative genomics and sequence-structure analyses, we comprehensively map the phyletic distribution and domain-level functional annotations of BREX proteins across all subtypes. Our analysis uncovers numerous previously uncharacterized domains with key functional implications and demonstrates that BrxA- and BrxB-like homologs are universally present across all subtypes, thereby redefining the core machinery of BREX. Our survey strikingly expands the BREX landscape by characterizing three newly defined RM-like systems, which we term BREX-Related (BR) systems, and establishes them as new subtypes that share multiple core components with BREX. Furthermore, we identified a novel composite anti-invader system that intriguingly integrates the BREX machinery with components derived from HerA/FtsK-based capture and Dpd defense systems, forming a unique multifaceted defense machinery. Notably, we identify an extensive repertoire of auxiliary and backup effectors recruited alongside the primary effectors across all BREX and BR systems, functioning to reinforce initial restriction responses and counter phage anti-defense mechanisms. Based on these findings, we propose a unified model organized around a multi-modal "sensing-modifying-restricting" functional architecture, defining the fundamental basis of the multi-layered BREX defense systems.

Indexed as

BacteriaBacterial ProteinsBacteriophagesPhylogenyProtein DomainsBacterial Proteins

Identifiers

PMID41591847
PMCPMC12839542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.